YOSHLARDA ONKOLOGIK KASALLIKLARNING SABABLARI, RIVOJLANISH OMILLARI VA OLDINI OLISH CHORALARI
Keywords:
Erta yoshda saraton, genetik moyillik, ekologik kanserogenlar, epigenetika, hayot tarzi, virusli onkogenez, saraton profilaktikasi, o‘sma mikro-muhiti, pediatrik onkologiya, immunoterapiya, aniq tibbiyotAbstract
Onkologik kasalliklar odatda yosh o'tishi bilan bog‘liq deb hisoblanadi, biroq so‘nggi yillarda yoshlar va o‘smirlar orasida saraton kasalliklarining ko‘payishi kuzatilmoqda. Erta yoshda onkologik kasalliklarning rivojlanish sabablari murakkab bo‘lib, ular irsiy moyillik, atrof-muhit omillari, hayot tarzi, virusli infeksiyalar va epigenetik o‘zgarishlar bilan bog‘liq bo‘lishi mumkin. Keksa yoshdagi saraton kasalliklaridan farqli o‘laroq, yoshlar orasida uchraydigan saraton turlari ko‘pincha tajovuzkorlik darajasi yuqori, o‘ziga xos o‘zgarishlarga ega va noyob sharoitlarda rivojlanadi. Ushbu maqolada yoshlarda saraton rivojlanishining asosiy xavf omillari, molekulyar mexanizmlari va profilaktika usullari batafsil tahlil qilinadi.
References
1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians. 2023;73(1):17-48.
2. Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The global cancer burden. Cancer. 2021;127(16):3029-3030.
3. Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011;144(5):646-674.
4. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56-61.
5. Llovet JM, Villanueva A. Liver cancer: Advances in treatment and personalized therapy. Nat Rev Clin Oncol. 2018;15(10):599-616.
6. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424.
7. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674.
8. Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7–30.
9. DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Sauer, A. G., Jemal, A., & Siegel, R. L. (2019). Breast cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69(6), 438–451.
10. Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer, 144(8), 1941–1953.
11. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249.
12. WHO International Agency for Research on Cancer. (2020). World Cancer Report: Cancer Research for Cancer Prevention. Lyon: IARC Press.
13. Jemal, A., Ward, E. M., Johnson, C. J., Cronin, K. A., Ma, J., Ryerson, A. B., … & Weir, H. K. (2017). Annual report to the nation on the status of cancer, 1975–2014. Cancer, 123(24), 5849–5878.
14. Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., & Ward, E. M. (2010). The global burden of cancer: Priorities for prevention. Carcinogenesis, 31(1), 100–110.
15. Kushi, L. H., Doyle, C., McCullough, M., Rock, C. L., Demark-Wahnefried, W., Bandera, E. V., … & Gansler, T. (2012). American Cancer Society Guidelines on nutrition and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians, 62(1), 30–67.
16. Schottenfeld, D., Fraumeni, J. F., & Colditz, G. A. (2018). Cancer Epidemiology and Prevention. New York: Oxford University Press.
17. Anand, P., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., … & Aggarwal, B. B. (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical Research, 25(9), 2097–2116.
18. Brawley, O. W. (2012). Trends in prostate cancer in the United States. Journal of the National Cancer Institute Monographs, 2012(45), 152–156.
